insights_auto
Bakit bumaba ang LCTX 4.01%?
Tingnan ang Higit pang Detalyechevron_right
LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
$0.95
arrow_downward
-4.01%(-0.040) 1D
$0.95
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 12, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa LCTX...
Buksan
$1.00
Mataas
$1.00
Mababa
$0.94
Mkt. cap
242.27M
Avg. na dami
1.41M
Dami
1.69M
Mataas nang 52-wk
$2.09
Mababa nang 52-wk
$0.88
EPS
-$0.14
Beta
1.60
Mga natitirang share
252.91M
Bilang ng mga empleyado
75
Buksan
$1.00
Mataas
$1.00
Mababa
$0.94
Mkt. cap
242.27M
Avg. na dami
1.41M
Dami
1.69M
Mataas nang 52-wk
$2.09
Mababa nang 52-wk
$0.88
EPS
-$0.14
Beta
1.60
Mga natitirang share
252.91M
Bilang ng mga empleyado
75
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
9 oras ang nakalipas
Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call
Profile
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Tungkol sa Lineage Cell Therapeutics Inc